G-protein βγ subunits in vasorelaxing and anti-endothelinergic effects of calcitonin gene-related peptide

British Journal of Pharmacology

Volumn 166, Issue 1, 2012, Pages 297-308

  Meens, M J P M T ^a   Mattheij, N J A ^a   Van Loenen, P B ^b   Spijkers, L J A ^b   Lemkens, P ^a   Nelissen, J ^a   Compeer, M G ^a   Alewijnse, A E ^b   De Mey, Jo G R ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

7 transmembrane domain receptors; CGRP receptor; endothelin; G proteins; vascular smooth muscle

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CYCLIC AMP; CYCLIC NUCLEOTIDE; ENDOTHELIN 1; FLUORESCEIN; GALLEIN; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; IODINE 125; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; M119; NITROPRUSSIDE SODIUM; POTASSIUM ION; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CELL ASSAY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; LIGAND BINDING; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

1-METHYL-3-ISOBUTYLXANTHINE; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; CYCLOHEXANES; GTP-BINDING PROTEIN BETA SUBUNITS; GTP-BINDING PROTEIN GAMMA SUBUNITS; HUMANS; ISOPROTERENOL; MALE; MESENTERIC ARTERIES; MUSCLE, SMOOTH, VASCULAR; NITROPRUSSIDE; RATS; RATS, INBRED WKY; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; VASODILATION; XANTHENES;

EID: 84859712236     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01774.x     Document Type: Article

References (58)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th Edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. Bagnato A, Spinella F, Rosano L, (2008). The endothelin axis in cancer: the promise and the challenges of molecularly targeted therapy. Can J Physiol Pharmacol 86: 473-484.
3. Bayewitch ML, Avidor-Reiss T, Levy R, Pfeuffer T, Nevo I, Simonds WF, et al,. (1998a). Differential modulation of adenylyl cyclases I and II by various G beta subunits. J Biol Chem 273: 2273-2276.
4. Bayewitch ML, Avidor-Reiss T, Levy R, Pfeuffer T, Nevo I, Simonds WF, et al,. (1998b). Inhibition of adenylyl cyclase isoforms V and VI by various Gbetagamma subunits. FASEB J 12: 1019-1025.
5. Beavo JA, (1995). cGMP inhibition of heart phosphodiesterase: is it clinically relevant? J Clin Invest 95: 445.
6. Bonacci TM, Mathews JL, Yuan C, Lehmann DM, Malik S, Wu D, et al,. (2006). Differential targeting of Gbetagamma-subunit signaling with small molecules. Science 312: 443-446.
7. Brain SD, Grant AD, (2004). Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84: 903-934.
8. Burnstock G, (2009). Autonomic neurotransmission: 60 years since sir Henry Dale. Annu Rev Pharmacol Toxicol 49: 1-30.
9. Casey LM, Pistner AR, Belmonte SL, Migdalovich D, Stolpnik O, Nwakanma FE, et al,. (2010). Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure. Circ Res 107: 532-539.
10. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D, (1997). The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389: 816-824.
11. Cervantes D, Crosby C, Xiang Y, (2010). Arrestin orchestrates crosstalk between G protein-coupled receptors to modulate the spatiotemporal activation of ERK MAPK. Circ Res 106: 79-88.
12. Chatterjee TK, Fisher RA, (1991). Multiple affinity forms of the calcitonin gene-related peptide receptor in rat cerebellum. Mol Pharmacol 39: 798-804.
13. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, et al,. (1990). Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5- isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265: 5267-5272.
14. De Mey J, Megens R, Fazzi G, (2008). Functional antagonism between endogenous neuropeptide Y and calcitonin gene-related peptide in mesenteric resistance arteries. J Pharmacol Exp Ther 324: 930-937.
15. De Mey J, Compeer M, Meens M, (2009). Endothelin-1, an endogenous irreversible agonist in search of an allosteric inhibitor. Mol Cell Pharmacol 1: 246-257.
16. De Mey JG, Compeer MG, Lemkens P, Meens MJ, (2011). ET(A)-receptor antagonists or allosteric modulators? Trends Pharmacol Sci 32: 345-351.
17. Fain JN, Pointer RH, Ward WF, (1972). Effects of adenosine nucleosides on adenylate cyclase, phosphodiesterase, cyclic adenosine monophosphate accumulation, and lipolysis in fat cells. J Biol Chem 247: 6866-6872.
18. Flaherty P, Radhakrishnan ML, Dinh T, Rebres RA, Roach TI, Jordan MI, et al,. (2008). A dual receptor crosstalk model of G-protein-coupled signal transduction. PLoS Comput Biol 4: e1000185.
19. Gales C, Van Durm JJ, Schaak S, Pontier S, Percherancier Y, Audet M, et al,. (2006). Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. Nat Struct Mol Biol 13: 778-786.
20. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B, (1995). Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol 48: 184-188.
21. Hendriks-Balk MC, van Loenen PB, Hajji N, Michel MC, Peters SL, Alewijnse AE, (2008). S1P receptor signalling and RGS proteins; expression and function in vascular smooth muscle cells and transfected CHO cells. Eur J Pharmacol 600: 1-9.
22. Heroux M, Breton B, Hogue M, Bouvier M, (2007). Assembly and signaling of CRLR and RAMP1 complexes assessed by BRET. Biochemistry 46: 7022-7033.
23. Hilgers RH, De Mey JG, (2009). Myoendothelial coupling in the mesenteric arterial bed; segmental differences and interplay between nitric oxide and endothelin-1. Br J Pharmacol 156: 1239-1247.
24. Ho TW, Edvinsson L, Goadsby PJ, (2010). CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol 6: 573-582.
25. Hynynen MM, Khalil RA, (2006). The vascular endothelin system in hypertension-recent patents and discoveries. Recent Pat Cardiovas Drug Discov 1: 95-108.
26. Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, et al,. (1987). K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun 142: 436-440.
27. Khodorova A, Montmayeur JP, Strichartz G, (2009). Endothelin receptors and pain. J Pain 10: 4-28.
28. Kirkby NS, Hadoke PW, Bagnall AJ, Webb DJ, (2008). The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house? Br J Pharmacol 153: 1105-1119.
29. Lehmann DM, Seneviratne AM, Smrcka AV, (2008). Small molecule disruption of G protein beta gamma subunit signaling inhibits neutrophil chemotaxis and inflammation. Mol Pharmacol 73: 410-418.
30. Mahon MJ, Bonacci TM, Divieti P, Smrcka AV, (2006). A docking site for G protein betagamma subunits on the parathyroid hormone 1 receptor supports signaling through multiple pathways. Mol Endocrinol 20: 136-146.
31. Masaki T, (2004). Historical review: endothelin. Trends Pharmacol Sci 25: 219-224.
32. Maton PN, Sutliff VE, Zhou ZC, Collins SM, Gardner JD, Jensen RT, (1988). Characterization of receptors for calcitonin gene-related peptide on gastric smooth muscle cells. Am J Physiol 254 (6 Pt 1): G789-G794.
33. Meens MJ, Fazzi GE, van Zandvoort MA, De Mey JG, (2009). Calcitonin gene-related peptide selectively relaxes contractile responses to endothelin-1 in rat mesenteric resistance arteries. J Pharmacol Exp Ther 331: 87-95.
34. Meens MJ, Compeer MG, Hackeng TM, van Zandvoort MA, Janssen BJ, De Mey JG, (2010). Stimuli of sensory-motor nerves terminate arterial contractile effects of endothelin-1 by CGRP and dissociation of ET-1/ET(A)-receptor complexes. PLoS ONE 5: e10917.
35. Meens MJ, Mattheij NJ, Nelissen J, Lemkens P, Compeer MG, Janssen BJ, et al,. (2011). Calcitonin gene-related peptide terminates long-lasting vasopressor responses to endothelin 1 in vivo. Hypertension 58: 99-106.
36. Mulvany M, Halpern W, (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41: 19-26.
37. Onaran HO, Costa T, Rodbard D, (1993). Beta gamma subunits of guanine nucleotide-binding proteins and regulation of spontaneous receptor activity: thermodynamic model for the interaction between receptors and guanine nucleotide-binding protein subunits. Mol Pharmacol 43: 245-256.
38. Powis G, Bonjouklian R, Berggren MM, Gallegos A, Abraham R, Ashendel C, et al,. (1994). Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res 54: 2419-2423.
39. Prezeau L, Rives ML, Comps-Agrar L, Maurel D, Kniazeff J, Pin JP, (2010). Functional crosstalk between GPCRs: with or without oligomerization. Curr Opin Pharmacol 10: 6-13.
40. Quitterer U, Lohse MJ, (1999). Crosstalk between Galpha(i)- and Galpha(q)-coupled receptors is mediated by Gbetagamma exchange. Proc Natl Acad Sci U S A 96: 10626-10631.
41. van Rossum D, Menard DP, Quirion R, (1993). Effect of guanine nucleotides and temperature on calcitonin gene-related peptide receptor binding sites in brain and peripheral tissues. Brain Res 617: 249-257.
42. Schindler M, Doods HN, (2002). Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [(3)H]BIBN4096BS. Eur J Pharmacol 442: 187-193.
43. 2+ channels. Trends Pharmacol Sci 18: 8-11.
44. Smrcka AV, (2008). G protein betagamma subunits: central mediators of G protein-coupled receptor signaling. Cell Mol Life Sci 65: 2191-2214.
45. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358.
46. Sunahara RK, Dessauer CW, Gilman AG, (1996). Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol 36: 461-480.
47. Supowit SC, Zhao H, Hallman DM, DiPette DJ, (1997). Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat. Hypertension 29: 945-950.
48. Szallasi A, Blumberg PM, (1999). Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 51: 159-212.
49. Talbodec A, Berkane N, Blandin V, Breittmayer JP, Ferrari E, Frelin C, et al,. (2000). Aspirin and sodium salicylate inhibit endothelin ETA receptors by an allosteric type of mechanism. Mol Pharmacol 57: 797-804.
50. Tubio MR, Fernandez N, Fitzsimons CP, Copsel S, Santiago S, Shayo C, et al,. (2010). Expression of a G protein-coupled receptor (GPCR) leads to attenuation of signaling by other GPCRs: experimental evidence for a spontaneous GPCR constitutive inactive form. J Biol Chem 285: 14990-14998.
51. Vanhaesebroeck B, Leevers SJ, Panayotou G, Waterfield MD, (1997). Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem Sci 22: 267-272.
52. Wang Y, Wang DH, (2004). Prevention of endothelin-1-induced increases in blood pressure: role of endogenous CGRP. Am J Physiol Heart Circ Physiol 287: H1868-H1874.
53. Weinryb I, Michel IM, (1974). Interactions of alpha-methylfluorene-2- acetic acid with adenylate cyclase. Biochem Pharmacol 23: 2411-2419.
54. Wimalawansa SJ, MacIntyre I, (1988). Calcitonin gene-related peptide and its specific binding sites in the cardiovascular system of rat. Int J Cardiol 20: 29-37.
55. Xie C, Wang DH, (2009). Ablation of transient receptor potential vanilloid 1 abolishes endothelin-induced increases in afferent renal nerve activity: mechanisms and functional significance. Hypertension 54: 1298-1305.
56. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al,. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
57. Yin HL, Janmey PA, (2003). Phosphoinositide regulation of the actin cytoskeleton. Annu Rev Physiol 65: 761-789.
58. Zheng H, Loh HH, Law PY, (2010). Agonist-selective signaling of G protein-coupled receptor: mechanisms and implications. IUBMB Life 62: 112-119.